CME Group (CME) President/CFO Lynne Fitzpatrick Receives Restricted Stock Award

What Happened Lynne Fitzpatrick, President and Chief Financial Officer of CME Group, was granted 4,088 restricted shares on 2026-09-15 valued at $275.09 each (total $1,124,568). To satisfy tax withholding on the vesting, she surrendered a total of 1,340 shares across 2026-09-15 and 2026-09-16, generating proceeds of $68,497, $75,650, $125,716 and $97,813 respectively (total surrendered value ≈ $367,676). The primary transaction is an award (acquisition) of restricted stock; the share surrenders were routine tax-withholding dispositions.

Key Details

• Transactions: Award (Code A) and tax-withholding share surrenders (Code F).
• Award: 4,088 RSUs on 2026-09-15 at $275.09 each, total value $1,124,568.
• Withholdings/dispositions:
  • 2026-09-15: 249 shares @ $275.09 → $68,497
  • 2026-09-15: 275 shares @ $275.09 → $75,650
  • 2026-09-15: 457 shares @ $275.09 → $125,716
  • 2026-09-16: 359 shares @ $272.46 → $97,813
  • Total surrendered: 1,340 shares, ≈ $367,676
• Shares owned after transaction: not specified in the filing.
• Footnotes: F1 — grant of restricted stock under the CME Group Omnibus Stock Plan vesting in four equal annual installments subject to continued service. F2 — shares surrendered to satisfy tax withholding on vesting.
• Filing timeliness: Report filed 2026-09-17 covering transactions on 2026-09-15 and 2026-09-16; appears timely (not noted as late).

Context Restricted stock grants are a common form of executive compensation and typically vest over time; the award itself is an acquisition on the company’s equity ledger, not an open-market purchase. The surrendered shares were used to cover tax withholding (a routine, non-discretionary transaction) and do not necessarily signal the insider’s view on the stock. Transaction codes: A = award/acquisition; F = tax withholding (shares surrendered).